2. Literaturverzeichnis

Das vollständige Literaturverzeichnis des "MicroBiota Guide" – die wissenschaftlichen Originalquellen hinter den Referenznummern, die in den Kapiteln erscheinen.

Was steht im Literaturverzeichnis?

Dieser Anhang versammelt das vollständige Literaturverzeichnis des Buches an einem Ort: jede wissenschaftliche Quelle, die in irgendeinem Kapitel des Bandes zitiert wird. Die Zahlen `[12]`, `[325]` und andere im Fließtext verweisen auf die unten aufgeführten Einträge – die Nummerierung läuft durch das gesamte Buch, sodass dieselbe Referenznummer `[N]` immer auf dieselbe Quelle verweist. Die weit überwiegende Mehrheit der aufgeführten Veröffentlichungen erschien in begutachteten Fachzeitschriften und ist auch in indexierten Datenbanken (PubMed/NCBI, Crossref) auffindbar, von angesehenen Fachverlagen.

Warum steht unter jedem Eintrag eine Zusammenfassung?

Unter jeder Quelle steht eine Kurzdarstellung von 5–6 Sätzen. Sie ist nicht das offizielle Abstract des Artikels, sondern eine kurze, allgemein verständliche Zusammenfassung, die den Hintergrund der Studie, die verwendete Methode, das wichtigste Ergebnis und dessen klinische oder praktische Bedeutung darstellt. Ihr Zweck ist es, den Leserinnen und Lesern eine rasche Entscheidung darüber zu ermöglichen, ob sich die vollständige Veröffentlichung zu lesen lohnt und ob sie zur eigenen Fragestellung oder zur Situation der Patientin oder des Patienten passt. Die Zusammenfassungen helfen Ihnen, sich auch ohne direkten Zugang zum Volltext zu orientieren.

Wie wird es benutzt?

Unter jedem Eintrag finden Sie die Zeile "Zitiert in": Ein Klick auf die dort angezeigte Kapitelnummer führt Sie zurück an die Stelle des Buches, an der die Quelle zitiert wird. Innerhalb dieses Kapitels bringt ein Klick auf die Markierung `[N]` die Leserin oder den Leser hierher, zum Literaturverzeichnis – Sie können sich also frei in beide Richtungen bewegen. Ein Klick auf die mit "Link" gekennzeichnete Quelle öffnet die Veröffentlichung auf der Seite des Verlags oder von NCBI, wo sich – sofern der Artikel frei zugänglich ist (Open Access) – auch der Volltext lesen lässt.

Literatur

[1] Sender R, Fuchs S, Milo R. Are We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans. Cell. 2016. Link

Short summary of the cited reference is in preparation.

[2] Qin J, Li R, Raes J et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010. Link

Short summary of the cited reference is in preparation.

[3] Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The Human Microbiome Project. Nature. 2007. Link

Short summary of the cited reference is in preparation.

[4] Lynch SV, Pedersen O. The Human Intestinal Microbiome in Health and Disease. N Engl J Med. 2016. Link

Short summary of the cited reference is in preparation.

[5] Thaiss CA, Zmora N, Levy M, Elinav E. The microbiome and innate immunity. Nature. 2016. Link

Short summary of the cited reference is in preparation.

[6] Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature. 2012. Link

Short summary of the cited reference is in preparation.

[7] van Nood E, Vrieze A, Nieuwdorp M et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013. Link

Short summary of the cited reference is in preparation.

[8] Ianiro G, Punčochář M, Karcher N et al. Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases. Nat Med. 2022. Link

Short summary of the cited reference is in preparation.

[9] Peery AF, Kelly CR, Kao D et al. AGA Clinical Practice Guideline on Fecal Microbiota-Based Therapies for Select Gastrointestinal Diseases. Gastroenterology. 2024. Link

Short summary of the cited reference is in preparation.

[10] Wild, C. P. Complementing the Genome with an 'Exposome': The Outstanding Challenge of Environmental Exposure Measurement in Molecular Epidemiology. Cancer Epidemiol Biomarkers Prev. 2005. Link

Short summary of the cited reference is in preparation.

[11] Rappaport SM, Smith MT. Epidemiology. Environment and Disease Risks. Science. 2010. Link

Short summary of the cited reference is in preparation.

[12] Zmora N, Zilberman-Schapira G, Suez J et al. Personalized Gut Mucosal Colonization Resistance to Empiric Probiotics Is Associated with Unique Host and Microbiome Features. Cell. 2018. Link

Short summary of the cited reference is in preparation.

[13] Sonnenburg JL, Gardner E. Microbiome tests: Ignore the hype. Science. 2016. Link

Short summary of the cited reference is in preparation.

[15] Jovel J, Patterson J, Wang W et al. Characterization of the human gut microbiome using 16S or WGS: a comparative study on the outcome of different analysis pipelines. Front Microbiol. 2016. Link

Short summary of the cited reference is in preparation.

[16] Sinha R, Abu-Ali G, Vogtmann E et al. Assessment of Variation in Microbial Community Amplicon Sequencing by the Microbiome Quality Control (MBQC) Project Consortium. Nature Biotechnology. 2017. Link

Short summary of the cited reference is in preparation.

[17] Salter SJ, Cox MJ, Turek EM et al. Reagent and Laboratory Contamination Can Critically Impact Sequence-Based Microbiome Analyses. BMC Biology. 2014. Link

Short summary of the cited reference is in preparation.

[18] Gloor GB, Macklaim JM, Pawlowsky-Glahn V, Egozcue JJ. Microbiome datasets are compositional: and this is not optional. Front Microbiol. 2017. Link

Short summary of the cited reference is in preparation.

[19] Costea PI, Zeller G, Sunagawa S et al. Towards Standards for Human Fecal Sample Processing in Metagenomic Studies. Nature Biotechnology. 2017. Link

Short summary of the cited reference is in preparation.

[21] McLaren MR, Willis AD, Callahan BJ. Consistent and Correctable Bias in Metagenomic Sequencing Experiments. eLife. 2019. Link

Short summary of the cited reference is in preparation.

[22] Sczyrba A, Hofmann P, Belmann P et al. Critical Assessment of Metagenome Interpretation -- A Benchmark of Metagenomics Software. Nature Methods. 2017. Link

Short summary of the cited reference is in preparation.

[23] Vandeputte D, Kathagen G, D'hoe K et al. Quantitative Microbiome Profiling Links Gut Community Variation to Microbial Load. Nature. 2017. Link

Short summary of the cited reference is in preparation.

[24] Sonnenburg JL, Bäckhed F. Diet–microbiota interactions as moderators of human metabolism. Nature. 2016. Link

Short summary of the cited reference is in preparation.

[25] Zierer J, Jackson MA, Kastenmüller G et al. The fecal metabolome as a functional readout of the gut microbiome. Nat Genet. 2018. Link

Short summary of the cited reference is in preparation.

[26] Dahl WJ, Zhu H, Guan LL. Fecal metabolomics reveals diet-dependent microbiome changes. Curr Dev Nutr. 2020. Link

Short summary of the cited reference is in preparation.

[28] Vétizou M, Pitt JM, Daillère R et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science. 2015. Link

Short summary of the cited reference is in preparation.

[29] Peery AF, Kelly CR, Kao D et al. AGA Clinical Practice Guideline on Fecal Microbiota-Based Therapies for Select Gastrointestinal Diseases. Gastroenterology. 2024. Link

Short summary of the cited reference is in preparation.

[30] Zuo T, Wong SH, Lam K et al. Bacteriophage transfer during faecal microbiota transplantation in Clostridium difficile infection is associated with treatment outcome. Gut. 2018. Link

Short summary of the cited reference is in preparation.

[31] Moayyedi P, Surette MG, Kim PT et al. Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial. Gastroenterology. 2015. Link

Short summary of the cited reference is in preparation.

[32] Paramsothy S, Nielsen S, Kamm MA et al. Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis. Gastroenterology. 2019. Link

Short summary of the cited reference is in preparation.

[33] Porcari S, Benech N, Valles-Colomer M et al. Key determinants of success in fecal microbiota transplantation: from microbiome to clinic. Cell Host Microbe. 2023. Link

Short summary of the cited reference is in preparation.

[34] Smillie CS, Sauk J, Gevers D et al. Strain tracking reveals the determinants of bacterial engraftment in the human gut following fecal microbiota transplantation. Cell Host Microbe. 2018. Link

Short summary of the cited reference is in preparation.

[35] Paramsothy S, Kamm MA, Kaakoush NO et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet. 2017. Link

Short summary of the cited reference is in preparation.

[36] Cammarota G, Ianiro G, Tilg H et al. European consensus conference on faecal microbiota transplantation in clinical practice. Gut. 2017. Link

Short summary of the cited reference is in preparation.

[37] Terveer EM, van Beurden YH, Goorhuis A et al. How to Establish and Run a Stool Bank. Clin Microbiol Infect. 2017. Link

Short summary of the cited reference is in preparation.

[38] Hvas CL, Møller Dahl A, Yarandi SS et al. Efficacy of Fecal Microbiota Transplantation in 2 Randomized Controlled Trials for CDI: Bowel Preparation and Retention Time Matter. Am J Gastroenterol. 2021. Link

Short summary of the cited reference is in preparation.

[39] Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F. From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites. Cell. 2016. Link

Short summary of the cited reference is in preparation.

[40] Singh T, Bhattacharya S et al. Proton pump inhibitor in upper gastrointestinal fecal microbiota transplant: A systematic review and analysis. J Gastroenterol Hepatol. 2020.

Short summary of the cited reference is in preparation.

[41] Mack I, Igna R, Unterseher L et al. Patients with Clostridium difficile Infection Show a Marked Reduction in Diverse Fecal Microbiota after Antibiotic Therapy and Subsequent Normalization after Fecal Microbiota Transplantation. Nutrients. 2018. Link

Short summary of the cited reference is in preparation.

[42] Dahl WJ, Zhu H, Guan X. Dietary Fiber and Gut Microbiota in the Propagation of Short-Chain Fatty Acids. Am J Clin Nutr. 2023. Link

Short summary of the cited reference is in preparation.

[43] Wallace, J. L. Prostaglandins, NSAIDs, and Gastric Mucosal Protection: Why Doesn't the Stomach Digest Itself? Physiol Rev. 2008. 2008. Link

Short summary of the cited reference is in preparation.

[44] Zipursky JS, Sidorsky TI, Freedman CA, Sidorsky MN, Kirkland KB. Patient attitudes toward the use of fecal microbiota transplantation in the treatment of recurrent Clostridium difficile infection. Clin Infect Dis. 2012. Link

Short summary of the cited reference is in preparation.

[45] Kao D, Roach B, Silva M et al. Effect of Oral Capsule– vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection: A Randomized Clinical Trial. JAMA. 2017. Link

Short summary of the cited reference is in preparation.

[46] Ianiro G, Bibbo S, Scaldaferri F et al. Fecal Microbiota Transplantation in Inflammatory Bowel Disease: Beyond the Excitement. Medicine (Baltimore). 2014. Link

Short summary of the cited reference is in preparation.

[47] Staley C, Khoruts A, Sadowsky MJ. Contemporary Applications of Fecal Microbiota Transplantation to Treat Intestinal Diseases in Humans. Arch Med Res. 2017. Link

Short summary of the cited reference is in preparation.

[48] Smith MB, Kelly C, Alm EJ. Policy: How to regulate faecal transplants. Nature. 2014. Link

Short summary of the cited reference is in preparation.

[49] DeFilipp Z, Bloom PP, Torres Soto M et al. Drug-Resistant E. coli Bacteremia (the presence of bacteria in the bloodstream) Transmitted by Fecal Microbiota Transplant. N Engl J Med. 2019. Link

Short summary of the cited reference is in preparation.

[50] Marcella C, Cui B, Kelly CR, Ianiro G, Cammarota G, Zhang F. Systematic review: the global incidence of faecal microbiota transplantation-related adverse events from 2000 to 2020. Aliment Pharmacol Ther. 2000. Link

Short summary of the cited reference is in preparation.

[51] Hourigan SK, Oliva-Hemker M. Fecal Microbiota Transplantation in Children: A Brief Review. Pediatr Res. 2016. Link

Short summary of the cited reference is in preparation.

[52] Cook MD, Allen JM, Pence BD et al. Exercise and gut immune function: evidence of alterations in colon immune cell homeostasis and microbiome characteristics with exercise training. Immunol Cell Biol. 2016. Link

Short summary of the cited reference is in preparation.

[53] Cryan JF, O'Riordan KJ, Cowan CSM et al. The Microbiota-Gut-Brain Axis. Physiol Rev. 2019. Link

Short summary of the cited reference is in preparation.

[54] Sokol H, Landman C, Seksik P et al. Fecal microbiota transplantation to maintain remission in Crohn's disease: a pilot randomized controlled study. Microbiome. 2020. Link

Short summary of the cited reference is in preparation.

[55] Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R. Bacterial community variation in human body habitats across space and time. Science. 2009. Link

Short summary of the cited reference is in preparation.

[56] Arpaia N, Campbell C, Fan X et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature. 2013. Link

Short summary of the cited reference is in preparation.

[57] Furusawa Y, Obata Y, Fukuda S et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013. Link

Short summary of the cited reference is in preparation.

[58] Baxter NT, Schmidt AW, Venkataraman A, Kim KS, Martens EC, Schloss PD. Dynamics of Human Gut Microbiota and Short-Chain Fatty Acids in Response to Dietary Interventions with Three Fermentable Fibers. mBio. 2019. Link

Short summary of the cited reference is in preparation.

[59] Thaiss CA, Zeevi D, Levy M et al. Transkingdom control of microbiota diurnal oscillations promotes metabolic homeostasis. Cell. 2014. Link

Short summary of the cited reference is in preparation.

[60] Benedict C, Vogel H, Jonas W et al. Gut microbiota and glucometabolic alterations in response to recurrent partial sleep deprivation in normal-weight young individuals. Mol Metab. 2016. Link

Short summary of the cited reference is in preparation.

[61] Estaki M, Pither J, Baumeister P et al. Cardiorespiratory fitness as a predictor of intestinal microbial diversity and distinct metagenomic functions. Microbiome. 2016. Link

Short summary of the cited reference is in preparation.

[62] Clarke SF, Murphy EF, O'Sullivan O et al. Exercise and associated dietary extremes impact on gut microbial diversity. Gut. 2014. Link

Short summary of the cited reference is in preparation.

[63] Ridlon JM, Kang DJ, Hylemon PB, Bajaj JS. Bile acids and the gut microbiome. Curr Opin Gastroenterol. 2014. Link

Short summary of the cited reference is in preparation.

[64] Valles-Colomer M, Falony G, Darzi Y et al. The neuroactive potential of the human gut microbiota in quality of life and depression. Nat Microbiol. 2019. Link

Short summary of the cited reference is in preparation.

[65] Khoruts A, Sadowsky MJ. Understanding the mechanisms of faecal microbiota transplantation. Nat Rev Gastroenterol Hepatol. 2016. Link

Short summary of the cited reference is in preparation.

[67] Li SS, Zhu A, Benes V et al. Durable coexistence of donor and recipient strains after fecal microbiota transplantation. Science. 2016. Link

Short summary of the cited reference is in preparation.

[69] Reynolds A, Mann J, Cummings J, Winter N, Mete E, Te Morenga L. Carbohydrate quality and human health: a series of systematic reviews and meta-analyses. Lancet. 2019. Link

Short summary of the cited reference is in preparation.

[70] Flint HJ, Scott KP, Louis P, Duncan SH. The role of the gut microbiota in nutrition and health. Nat Rev Microbiol. 2012. Link

Short summary of the cited reference is in preparation.

[71] Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ. The role of butyrate on colonic function. Aliment Pharmacol Ther. 2008. Link

Short summary of the cited reference is in preparation.

[72] Gibson GR, Hutkins R, Sanders ME et al. The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol. 2017. Link

Short summary of the cited reference is in preparation.

[73] Sonnenburg ED, Sonnenburg JL. Starving our microbial self: the deleterious consequences of a diet deficient in microbiota-accessible carbohydrates. Cell Metab. 2014. Link

Short summary of the cited reference is in preparation.

[74] Rooks MG, Garrett WS. Gut microbiota, metabolites and host immunity. Nat Rev Immunol. 2016. Link

Short summary of the cited reference is in preparation.

[75] Keys A, Menotti A, Karvonen MJ et al. The diet and 15-year death rate in the Seven Countries Study. Am J Epidemiol. 1986. Link

Short summary of the cited reference is in preparation.

[76] Estruch R, Ros E, Salas-Salvadó J et al. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts. N Engl J Med. 2018. Link

Short summary of the cited reference is in preparation.

[77] De Filippis F, Pellegrini N, Vannini L et al. High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome. Gut. 2016. Link

Short summary of the cited reference is in preparation.

[78] Selma MV, Espín JC, Tomás-Barberán FA. Interaction between phenolics and gut microbiota: role in human health. J Agric Food Chem. 2009. Link

Short summary of the cited reference is in preparation.

[79] Koeth RA, Wang Z, Levison BS et al. Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013. Link

Short summary of the cited reference is in preparation.

[80] Gutiérrez-Díaz I, Fernández-Navarro T, Sánchez B, Margolles A, González S. Mediterranean diet and faecal microbiota: a transversal study. Food Funct. 2016. Link

Short summary of the cited reference is in preparation.

[81] Meslier V, Laiola M, Roager HM et al. Mediterranean diet intervention in overweight and obese subjects lowers plasma cholesterol and causes changes in the gut microbiome and metabolome independently of energy intake. Gut. 2020. Link

Short summary of the cited reference is in preparation.

[82] Fernandez MA, Marette A. Potential Health Benefits of Combining Yogurt and Fruits Based on Their Probiotic and Prebiotic Properties. Adv Nutr. 2017. Link

Short summary of the cited reference is in preparation.

[83] Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr. 1995. Link

Short summary of the cited reference is in preparation.

[84] Bode, L. Human milk oligosaccharides: every baby needs a sugar mama. Glycobiology. 2012. Link

Short summary of the cited reference is in preparation.

[85] Holscher, H. D. Dietary fiber and prebiotics and the gastrointestinal microbiota. Gut Microbes. 2017. Link

Short summary of the cited reference is in preparation.

[86] Deleu S, Machiels K, Raes J, Verbeke K, Vermeire S. Short chain fatty acids and its producing organisms: An overlooked therapy for IBD? EBioMedicine. 2021. 2021. Link

Short summary of the cited reference is in preparation.

[87] Sonnenburg JL, Sonnenburg ED. Vulnerability of the industrialised microbiota. Science. 2019. Link

Short summary of the cited reference is in preparation.

[88] Deehan EC, Yang C, Perez-Muñoz ME et al. Precision Microbiome Modulation with Discrete Dietary Fiber Structures Directs Short-Chain Fatty Acid Production. Cell Host Microbe. 2020. Link

Short summary of the cited reference is in preparation.

[89] Metchnikoff, E. The Prolongation of Life: Optimistic Studies. London: Heinemann. 1907. Link

Short summary of the cited reference is in preparation.

[90] FAO/WHO. Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria. Joint FAO/WHO Expert Consultation Report. 2001. (IV-4). 2001. Link

Short summary of the cited reference is in preparation.

[91] Suez J, Zmora N, Segal E, Elinav E. The pros, cons, and many unknowns of probiotics. Nat Med. 2019. Link

Short summary of the cited reference is in preparation.

[92] Hill C, Guarner F, Reid G et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014. Link

Short summary of the cited reference is in preparation.

[93] Goldenberg JZ, Yap C, Lytvyn L et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev. 2017. Link

Short summary of the cited reference is in preparation.

[95] McFarland, L. V. Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: a systematic review. BMJ Open. 2014. Link

Short summary of the cited reference is in preparation.

[96] Shen NT, Maw A, Tmanova LL et al. Timely Use of Probiotics in Hospitalized Adults Prevents Clostridium difficile Infection: A Systematic Review With Meta-Regression Analysis. Gastroenterology. 2017. Link

Short summary of the cited reference is in preparation.

[97] Shortt, C. The probiotic century: historical and current perspectives. Trends Food Sci Technol. 1999. Link

Short summary of the cited reference is in preparation.

[98] Swanson KS, Gibson GR, Hutkins R et al. The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics. Nat Rev Gastroenterol Hepatol. 2020. Link

Short summary of the cited reference is in preparation.

[99] Schrezenmeir J, de Vrese M. Probiotics, prebiotics, and synbiotics – approaching a definition. Am J Clin Nutr. 2001. Link

Short summary of the cited reference is in preparation.

[100] Markowiak P, Śliżewska K. Effects of Probiotics, Prebiotics, and Synbiotics on Human Health. Nutrients. 2017. Link

Short summary of the cited reference is in preparation.

[101] Kukkonen K, Savilahti E, Haahtela T et al. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol. 2007. Link

Short summary of the cited reference is in preparation.

[102] Bermudez-Brito M, Plaza-Díaz J, Muñoz-Quezada S, Gómez-Llorente C, Gil A. Probiotic mechanisms of action. Ann Nutr Metab. 2012. Link

Short summary of the cited reference is in preparation.

[103] Asemi Z, Zare Z, Shakeri H, Sabihi SS, Esmaillzadeh A. Effect of multispecies probiotic supplements on metabolic profiles, hs-CRP, and oxidative stress in patients with type 2 diabetes. Ann Nutr Metab. 2013. Link

Short summary of the cited reference is in preparation.

[104] Farnworth, E. R. Kefir – a complex probiotic. Food Sci Technol Bull Funct Foods. 2005. Link

Short summary of the cited reference is in preparation.

[105] Bourrie BCT, Willing BP, Cotter PD. The Microbiota and Health Promoting Characteristics of the Fermented Beverage Kefir. Front Microbiol. 2016. Link

Short summary of the cited reference is in preparation.

[106] Wastyk HC, Fragiadakis GK, Perelman D et al. Gut-microbiota-targeted diets modulate human immune status. Cell. 2021. Link

Short summary of the cited reference is in preparation.

[107] Marco ML, Heeney D, Binda S et al. Health benefits of fermented foods: microbiota and beyond. Curr Opin Biotechnol. 2017. Link

Short summary of the cited reference is in preparation.

[108] Dimidi E, Cox SR, Rossi M, Whelan K. Fermented Foods: Definitions and Characteristics, Impact on the Gut Microbiota and Effects on Gastrointestinal Health and Disease. Nutrients. 2019. Link

Short summary of the cited reference is in preparation.

[109] O'Sullivan O, Coakley M, Lakshminarayanan B et al. Alterations in intestinal microbiota of elderly Irish subjects post-antibiotic therapy. J Antimicrob Chemother. 2013. Link

Short summary of the cited reference is in preparation.

[110] Pasteur, L. Mémoire sur la fermentation appelée lactique. Mémoires de la Société des Sciences de l'Agriculture et des Arts de Lille. 1857. Link

Short summary of the cited reference is in preparation.

[111] Geison, G. L. The Private Science of Louis Pasteur. Princeton: Princeton University Press. 1995. Link

Short summary of the cited reference is in preparation.

[112] Marsh AJ, O'Sullivan O, Hill C, Ross RP, Cotter PD. Sequence-based analysis of the bacterial and fungal compositions of multiple kombucha (tea fungus) samples. Food Microbiol. 2014. Link

Short summary of the cited reference is in preparation.

[113] Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 1992. Link

Short summary of the cited reference is in preparation.

[114] Novelle MG, Wahl D, Diéguez C, Bernier M, de Cabo R. Resveratrol supplementation: Where are we now and where should we go? Ageing Res Rev. 2015. 2015. Link

Short summary of the cited reference is in preparation.

[115] Espín JC, González-Sarrías A, Tomás-Barberán FA. The gut microbiota: A key factor in the therapeutic effects of (poly)phenols. Biochem Pharmacol. 2017. Link

Short summary of the cited reference is in preparation.

[116] Dueñas M, Muñoz-González I, Cueva C et al. A survey of modulation of gut microbiota by dietary polyphenols. Biomed Res Int. 2015. Link

Short summary of the cited reference is in preparation.

[117] Singh RK, Chang HW, Yan D et al. Influence of diet on the gut microbiota and implications for human health. J Transl Med. 2017. Link

Short summary of the cited reference is in preparation.

[118] Bang HO, Dyerberg J, Sinclair HM. The composition of the Eskimo food in north western Greenland. Am J Clin Nutr. 1980. Link

Short summary of the cited reference is in preparation.

[119] Dyerberg J, Bang HO, Stoffersen E, Moncada S, Vane JR. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet. 1978. 1978. Link

Short summary of the cited reference is in preparation.

[120] Calder, P. C. Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochem Soc Trans. 2017. Link

Short summary of the cited reference is in preparation.

[121] Simopoulos, A. P. An Increase in the Omega-6/Omega-3 Fatty Acid Ratio Increases the Risk for Obesity. Nutrients. 2016. Link

Short summary of the cited reference is in preparation.

[122] Costantini L, Molinari R, Farinon B, Merendino N. Impact of Omega-3 Fatty Acids on the Gut Microbiota. Int J Mol Sci. 2017. Link

Short summary of the cited reference is in preparation.

[123] Noriega BS, Sanchez-Gonzalez MA, Salyakina D, Coffman J. Understanding the impact of omega-3 rich diet on the gut microbiota. Case Rep Med. 2016. Link

Short summary of the cited reference is in preparation.

[124] Cani PD, Amar J, Iglesias MA et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007. Link

Short summary of the cited reference is in preparation.

[125] O'Keefe SJD, Li JV, Lahti L et al. Fat, fibre and cancer risk in African Americans and rural Africans. Nat Commun. 2015. Link

Short summary of the cited reference is in preparation.

[126] Topping DL, Clifton PM. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev. 2001. Link

Short summary of the cited reference is in preparation.

[127] Flint HJ, Scott KP, Duncan SH, Louis P, Forano E. Microbial degradation of complex carbohydrates in the gut. Gut Microbes. 2012. Link

Short summary of the cited reference is in preparation.

[128] Ze X, Duncan SH, Louis P, Flint HJ. Ruminococcus bromii is a keystone species for the degradation of resistant starch in the human colon. ISME J. 2012. Link

Short summary of the cited reference is in preparation.

[130] Snow, J. On the Mode of Communication of Cholera. 2nd ed. London: John Churchill. 1965. Link

Short summary of the cited reference is in preparation.

[131] Koch, R. Ueber die Cholerabacterien. Dtsch Med Wochenschr. 1884. Link

Short summary of the cited reference is in preparation.

[132] Johansson ME, Sjövall H, Hansson GC. The gastrointestinal mucus system in health and disease. Nat Rev Gastroenterol Hepatol. 2013. Link

Short summary of the cited reference is in preparation.

[133] Cotillard A, Kennedy SP, Kong LC et al. Dietary intervention impact on gut microbial gene richness. Nature. 2013. Link

Short summary of the cited reference is in preparation.

[134] Turnbaugh PJ, Hamady M, Yatsunenko T et al. A core gut microbiota in obese and lean twins. Nature. 2009. Link

Short summary of the cited reference is in preparation.

[135] Mowat AM, Agace WW. Regional specialization within the intestinal immune system. Nat Rev Immunol. 2014. Link

Short summary of the cited reference is in preparation.

[136] Fraser, G. E. Associations between diet and cancer, ischemic heart disease, and all-cause mortality in non-Hispanic white California Seventh-day Adventists. Am J Clin Nutr. 1999. Link

Short summary of the cited reference is in preparation.

[137] Orlich MJ, Singh PN, Sabaté J et al. Vegetarian dietary patterns and mortality in Adventist Health Study 2. JAMA Intern Med. 2013. Link

Short summary of the cited reference is in preparation.

[138] Conlon MA, Bird AR. The impact of diet and lifestyle on gut microbiota and human health. Nutrients. 2015. Link

Short summary of the cited reference is in preparation.

[139] Russell WR, Gratz SW, Duncan SH et al. High-protein, reduced-carbohydrate weight-loss diets promote metabolite profiles likely to be detrimental to colonic health. Am J Clin Nutr. 2011. Link

Short summary of the cited reference is in preparation.

[140] Flint HJ, Duncan SH, Scott KP, Louis P. Links between diet, gut microbiota composition and gut metabolism. Proc Nutr Soc. 2015. Link

Short summary of the cited reference is in preparation.

[141] David LA, Maurice CF, Carmody RN et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014. Link

Short summary of the cited reference is in preparation.

[142] Burr ML, Fehily AM, Gilbert JF et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet. 1989. Link

Short summary of the cited reference is in preparation.

[143] Tremaroli V, Bäckhed F. Functional interactions between the gut microbiota and host metabolism. Nature. 2012. Link

Short summary of the cited reference is in preparation.

[144] Cani PD, Amar J, Iglesias MA et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007. Link

Short summary of the cited reference is in preparation.

[145] Key TJ, Appleby PN, Rosell MS. Health effects of vegetarian and vegan diets. Proc Nutr Soc. 2006. Link

Short summary of the cited reference is in preparation.

[146] Tong TYN, Appleby PN, Bradbury KE et al. Risks of ischaemic heart disease and stroke in meat eaters, fish eaters, and vegetarians over 18 years of follow-up: results from the prospective EPIC-Oxford study. BMJ. 2019. Link

Short summary of the cited reference is in preparation.

[147] Tomova A, Bukovsky I, Rembert E et al. The Effects of Vegetarian and Vegan Diets on Gut Microbiota. Front Nutr. 2019. Link

Short summary of the cited reference is in preparation.

[148] Tap J, Furet JP, Bensaada M et al. Gut microbiota richness promotes its stability upon increased dietary fibre intake in healthy adults. Environ Microbiol. 2015. Link

Short summary of the cited reference is in preparation.

[149] Ridaura VK, Faith JJ, Rey FE et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science. 2013. Link

Short summary of the cited reference is in preparation.

[150] Zinöcker MK, Lindseth IA. The Western Diet–Microbiome-Host Interaction and Its Role in Metabolic Disease. Nutrients. 2018. Link

Short summary of the cited reference is in preparation.

[151] Hehemann JH, Correc G, Barbeyron T et al. Transfer of carbohydrate-active enzymes from marine bacteria to Japanese gut microbiota. Nature. 2010. Link

Short summary of the cited reference is in preparation.

[152] O'Sullivan L, Murphy B, McLoughlin P et al. Prebiotics from marine macroalgae for human and animal health applications. Mar Drugs. 2010. Link

Short summary of the cited reference is in preparation.

[153] Devkota S, Wang Y, Musch MW et al. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature. 2012. Link

Short summary of the cited reference is in preparation.

[154] Suez J, Korem T, Zeevi D et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature. 2014. Link

Short summary of the cited reference is in preparation.

[155] Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006. Link

Short summary of the cited reference is in preparation.

[156] Wang Z, Klipfell E, Bennett BJ et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011. Link

Short summary of the cited reference is in preparation.

[157] Tang WH, Hazen SL. The contributory role of gut microbiota in cardiovascular disease. J Clin Invest. 2014. Link

Short summary of the cited reference is in preparation.

[158] Bastide NM, Pierre FH, Corpet DE et al. Red Meat-Derived Nitroso Compounds, Lipid Peroxidation Products and Colorectal Cancer. Crit Rev Food Sci Nutr. 2016. Link

Short summary of the cited reference is in preparation.

[159] Chassaing B, Koren O, Goodrich JK et al. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature. 2015. Link

Short summary of the cited reference is in preparation.

[160] Chassaing B, Van de Wiele T, De Bodt J, Marzorati M, Gewirtz AT. Dietary emulsifiers directly alter human microbiota composition and gene expression ex vivo potentiating intestinal inflammation. Gut. 2017. Link

Short summary of the cited reference is in preparation.

[161] Desai MS, Seekatz AM, Koropatkin NM et al. A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell. 2016. Link

Short summary of the cited reference is in preparation.

[162] Suez J, Cohen Y, Valdés-Mas R et al. Personalized microbiome-driven effects of non-nutritive sweeteners on human glucose tolerance. Cell. 2022. Link

Short summary of the cited reference is in preparation.

[163] Zmora N, Suez J, Elinav E. You are what you eat: diet, health and the gut microbiota. Nat Rev Gastroenterol Hepatol. 2019. Link

Short summary of the cited reference is in preparation.

[164] Ruiz-Ojeda FJ, Plaza-Díaz J, Sáez-Lara MJ, Gil A. Effects of Sweeteners on the Gut Microbiota: A Review of Experimental Studies and Clinical Trials. Adv Nutr. 2019. Link

Short summary of the cited reference is in preparation.

[165] McCann D, Barrett A, Cooper A et al. Food additives and hyperactive behaviour in 3-year-old and 8/9-year-old children in the community: a randomised, double-blinded, placebo-controlled trial. Lancet. 2007. Link

Short summary of the cited reference is in preparation.

[166] European Food Safety Authority (EFSA). Scientific Opinion on the re-evaluation of six food colours. EFSA Journal. 2009. Link

Short summary of the cited reference is in preparation.

[167] Duan Y, Llorente C, Lang S et al. Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease. Nature. 2019. Link

Short summary of the cited reference is in preparation.

[168] Szabo, G. Gut-liver axis in alcoholic liver disease. Gastroenterology. 2015. Link

Short summary of the cited reference is in preparation.

[169] Leclercq S, Matamoros S, Cani PD et al. Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. Proc Natl Acad Sci USA. 2014. Link

Short summary of the cited reference is in preparation.

[170] Bishehsari F, Magno E, Swanson G et al. Alcohol and Gut-Derived Inflammation. Alcohol Res. 2017. Link

Short summary of the cited reference is in preparation.

[171] Yan AW, Fouts DE, Brandl J et al. Enteric dysbiosis associated with a mouse model of alcoholic liver disease. Hepatology. 2011. Link

Short summary of the cited reference is in preparation.

[172] Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology. 2014. Link

Short summary of the cited reference is in preparation.

[173] Staudacher HM, Whelan K, Irving PM, Lomer MC. Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. J Hum Nutr Diet. 2011. Link

Short summary of the cited reference is in preparation.

[174] Halmos EP, Christophersen CT, Bird AR, Shepherd SJ, Gibson PR, Muir JG. Diets that differ in their FODMAP content alter the colonic luminal microenvironment. Gut. 2015. Link

Short summary of the cited reference is in preparation.

[175] Gibson PR, Shepherd SJ. Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach. J Gastroenterol Hepatol. 2010. Link

Short summary of the cited reference is in preparation.

[176] Staudacher HM, Lomer MCE, Anderson JL et al. Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr. 2012. Link

Short summary of the cited reference is in preparation.

[177] De Palma G, Nadal I, Collado MC, Sanz Y. Effects of a gluten-free diet on gut microbiota and immune function in healthy adult volunteers. Br J Nutr. 2009. Link

Short summary of the cited reference is in preparation.

[178] Sanz Y, De Palma G. Gut microbiota, diet and chronic metabolic diseases. In: Proceedings of the Nutrition Society. 2009. Link

Short summary of the cited reference is in preparation.

[179] Nistal E, Caminero A, Herrán AR et al. Differences of small intestinal bacteria populations in adults and children with/without celiac disease. Influence of age, gluten diet, and disease. Inflamm Bowel Dis. 2012. Link

Short summary of the cited reference is in preparation.

[180] Setchell KDR, Brown NM, Lydeking-Olsen E. The clinical importance of the metabolite equol – a clue to the effectiveness of soy and its isoflavones. J Nutr. 2002. Link

Short summary of the cited reference is in preparation.

[181] Decroos K, Vanhemmens S, Cattoir S, Boon N, Verstraete W. Isolation and characterisation of an equol-producing mixed microbial culture from a human faecal sample. Arch Microbiol. 2005. Link

Short summary of the cited reference is in preparation.

[182] Frankenfeld CL, Atkinson C, Wahala K, Lampe JW. Obesity prevalence in relation to gut microbial environments capable of producing equol or O-desmethylangolensin from the isoflavone daidzein. Eur J Clin Nutr. 2012. Link

Short summary of the cited reference is in preparation.

[183] Wrangham, R. Catching Fire: How Cooking Made Us Human. New York: Basic Books. 2009. Link

Short summary of the cited reference is in preparation.

[184] Carmody RN, Wrangham RW. Cooking and the human commitment to a high-quality diet. Cold Spring Harb Symp Quant Biol. 2009. Link

Short summary of the cited reference is in preparation.

[185] Carmody RN, Gerber GK, Luevano JM et al. Diet dominates host genotype in shaping the murine gut microbiota. Cell Host Microbe. 2015. Link

Short summary of the cited reference is in preparation.

[186] Lichtenberg SS, Sivaganesan M, Shanks OC. Microbiome methods to assess produce quality and safety. mSphere. 2021. Link

Short summary of the cited reference is in preparation.

[187] Pham ND, Kim HJ, Kim IH et al. The impact of production system on microbiome and safety of fresh-cut vegetables. Front Microbiol. 2021. Link

Short summary of the cited reference is in preparation.

[188] Hanski I, von Hertzen L, Fyhrquist N et al. Environmental biodiversity, human microbiota, and allergy are interrelated. Proc Natl Acad Sci U S A. 2012. Link

Short summary of the cited reference is in preparation.

[190] Leone V, Gibbons SM, Martinez K et al. Effects of diurnal variation of gut microbes and high-fat feeding on host circadian clock function and metabolism. Cell Host Microbe. 2015. Link

Short summary of the cited reference is in preparation.

[191] Liang X, FitzGerald GA. Timing the Microbes: The Circadian Rhythm of the Gut Microbiome. J Biol Rhythms. 2017. Link

Short summary of the cited reference is in preparation.

[192] Chaix A, Zarrinpar A, Miu P, Panda S. Time-restricted feeding is a preventative and therapeutic intervention against diverse nutritional challenges. Cell Metab. 2014. Link

Short summary of the cited reference is in preparation.

[193] Zarrinpar A, Chaix A, Yooseph S, Panda S. Diet and feeding pattern affect the diurnal dynamics of the gut microbiome. Cell Metab. 2014. Link

Short summary of the cited reference is in preparation.

[194] Tian S, Li J, Li L et al. Intermittent fasting modulates the gut microbiota during Ramadan. Nature Commun. 2020. Link

Short summary of the cited reference is in preparation.

[195] Li L, Su Y, Li F et al. The effects of daily fasting hours on shaping gut microbiota in mice. BMC Microbiol. 2020. Link

Short summary of the cited reference is in preparation.

[196] McCay CM, Crowell MF, Maynard LA. The effect of retarded growth upon the length of life span and upon the ultimate body size. J Nutr. 1935. Link

Short summary of the cited reference is in preparation.

[197] Fontana L, Partridge L. Promoting health and longevity through diet: from model organisms to humans. Cell. 2015. Link

Short summary of the cited reference is in preparation.

[198] Ma X, Hua J, Li Z. Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells. J Hepatol. 2008. Link

Short summary of the cited reference is in preparation.

[199] Thaiss CA, Levy M, Korem T et al. Microbiota diurnal rhythmicity programs host transcriptome oscillations. Cell. 2016. Link

Short summary of the cited reference is in preparation.

[200] Cheung SG, Goldenthal AR, Uhlemann AC, Mann JJ, Miller JM, Sublette ME. Systematic review of gut microbiota and major depression. Front Psychiatry. 2019. Link

Short summary of the cited reference is in preparation.

[201] Irwin MR, Opp MR. Sleep health: reciprocal regulation of sleep and innate immunity. Neuropsychopharmacology. 2017. Link

Short summary of the cited reference is in preparation.

[202] Barton W, Penney NC, Cronin O et al. The microbiome of professional athletes differs from that of more sedentary subjects in composition and particularly at the functional metabolic level. Gut. 2018. Link

Short summary of the cited reference is in preparation.

[203] Cronin O, Barton W, Skuse P et al. A prospective metagenomic and metabolomic analysis of the impact of exercise and/or whey protein supplementation on the gut microbiome of sedentary adults. mSystems. 2018. Link

Short summary of the cited reference is in preparation.

[204] Allen JM, Mailing LJ, Niemiro GM et al. Exercise alters gut microbiota composition and function in lean and obese humans. Med Sci Sports Exerc. 2018. Link

Short summary of the cited reference is in preparation.

[205] Scheiman J, Luber JM, Chavkin TA et al. Meta-omics analysis of elite athletes identifies a performance-enhancing microbe that functions via lactate metabolism. Nat Med. 2019. Link

Short summary of the cited reference is in preparation.

[206] Laukkanen T, Khan H, Zaccardi F, Laukkanen JA. Association between sauna bathing and fatal cardiovascular and all-cause mortality events. JAMA Intern Med. 2015. Link

Short summary of the cited reference is in preparation.

[207] Mayer EA, Tillisch K, Gupta A. Gut/brain axis and the microbiota. J Clin Invest. 2015. Link

Short summary of the cited reference is in preparation.

[208] Bailey MT, Dowd SE, Galley JD, Hufnagle AR, Allen RG, Lyte M. Exposure to a social stressor alters the structure of the intestinal microbiota: implications for stressor-induced immunomodulation. Brain Behav Immun. 2011. Link

Short summary of the cited reference is in preparation.

[209] Dinan TG, Cryan JF. The microbiome-gut-brain axis in health and disease. Gastroenterol Clin North Am. 2017. Link

Short summary of the cited reference is in preparation.

[210] Bhasin MK, Dusek JA, Chang BH et al. Relaxation response induces temporal transcriptome changes in energy metabolism, insulin secretion and inflammatory pathways. PLoS ONE. 2013. Link

Short summary of the cited reference is in preparation.

[211] Karl JP, Hatch AM, Arcidiacono SM et al. Effects of Psychological, Environmental and Physical Stressors on the Gut Microbiota. Front Microbiol. 2018. Link

Short summary of the cited reference is in preparation.

[212] Lackner JM, Jaccard J, Keefer L et al. Improvement in gastrointestinal symptoms after cognitive behavior therapy for refractory irritable bowel syndrome. Gastroenterology. 2018. Link

Short summary of the cited reference is in preparation.

[213] Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012. Link

Short summary of the cited reference is in preparation.

[214] Kelly JR, Borre Y, O'Brien C et al. Transferring the blues: depression-associated gut microbiota induces neurobehavioural changes in the rat. J Psychiatr Res. 2016. Link

Short summary of the cited reference is in preparation.

[215] Song SJ, Lauber C, Costello EK et al. Cohabiting family members share microbiota with one another and with their dogs. eLife. 2013. Link

Short summary of the cited reference is in preparation.

[216] Tung J, Barreiro LB, Burns MB et al. Social networks predict gut microbiome composition in wild baboons. eLife. 2015. Link

Short summary of the cited reference is in preparation.

[217] Blaser, M. J. Missing Microbes: How the Overuse of Antibiotics Is Fueling Our Modern Plagues. New York: Henry Holt. 2014. Link

Short summary of the cited reference is in preparation.

[218] Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci USA. 2011. Link

Short summary of the cited reference is in preparation.

[219] Jernberg C, Löfmark S, Edlund C, Jansson JK. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J. 2007. Link

Short summary of the cited reference is in preparation.

[220] Huang EY, Inoue T, Leone VA et al. Using corticosteroids to reshape the gut microbiota: implications for inflammatory bowel diseases. Inflamm Bowel Dis. 2015. Link

Short summary of the cited reference is in preparation.

[221] Wu H, Esteve E, Tremaroli V et al. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat Med. 2017. Link

Short summary of the cited reference is in preparation.

[222] Forslund K, Hildebrand F, Nielsen T et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature. 2015. Link

Short summary of the cited reference is in preparation.

[223] Guo Y, Crnkovic CM, Won KJ et al. Commensal gut bacteria convert the immunosuppressant tacrolimus to less potent metabolites by microbial metabolism. Drug Metab Dispos. 2019. Link

Short summary of the cited reference is in preparation.

[224] Lee JR, Muthukumar T, Dadhania D et al. Gut microbiota and tacrolimus dosing in kidney transplantation. PLoS ONE. 2015. Link

Short summary of the cited reference is in preparation.

[225] Jackson MA, Goodrich JK, Maxan ME et al. Proton pump inhibitors alter the composition of the gut microbiota. Gut. 2016. Link

Short summary of the cited reference is in preparation.

[226] Imhann F, Bonder MJ, Vich Vila A et al. Proton pump inhibitors affect the gut microbiota. Gut. 2016. Link

Short summary of the cited reference is in preparation.

[227] Syer SD, Wallace JL, Vong L, McKnight W, Sharkey KA, Blackler RW. Concurrence of endoscopic and symptomatic ulcers with antibiotic treatment of Helicobacter pylori. Dig Dis Sci. 2015. Link

Short summary of the cited reference is in preparation.

[228] Lanas A, Chan FKL. Peptic ulcer disease. Lancet. 2017. Link

Short summary of the cited reference is in preparation.

[229] Maier L, Pruteanu M, Kuhn M et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature. 2018. Link

Short summary of the cited reference is in preparation.

[230] Baker JM, Al-Nakkash L, Herbst-Kralovetz MM. Estrogen-gut microbiome axis: physiological and clinical implications. Maturitas. 2017. Link

Short summary of the cited reference is in preparation.

[231] Flores R, Shi J, Fuhrman B et al. Fecal microbial determinants of fecal and serum estrogens and estrogen metabolites. BMC Microbiol. 2012. Link

Short summary of the cited reference is in preparation.

[232] Zuo T, Ng SC. The gut microbiota in the pathogenesis and therapeutics of inflammatory bowel disease. Front Microbiol. 2018. Link

Short summary of the cited reference is in preparation.

[233] Sokol H, Leducq V, Aschard H et al. Fungal microbiota dysbiosis in IBD. Gut. 2017. Link

Short summary of the cited reference is in preparation.

[234] Routy B, Le Chatelier E, Derosa L et al. Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors. Science. 2018. Link

Short summary of the cited reference is in preparation.

[235] Gopalakrishnan V, Spencer CN, Nezi L et al. Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients. Science. 2018. Link

Short summary of the cited reference is in preparation.

[236] Tropini C, Moss EL, Merrill BD et al. Transient osmotic perturbation causes long-term alteration to the gut microbiota. Cell. 2018. Link

Short summary of the cited reference is in preparation.

[237] Smaill FM, Grivell RM. Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section. Cochrane Database Syst Rev. 2014. Link

Short summary of the cited reference is in preparation.

[238] Dominguez-Bello MG, Costello EK, Contreras M et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA. 2010. Link

Short summary of the cited reference is in preparation.

[239] Stokholm J, Blaser MJ, Thorsen J et al. Maturation of the gut microbiome and risk of asthma in childhood. Nat Commun. 2018. Link

Short summary of the cited reference is in preparation.

[240] Vieira-Silva S, Falony G, Belda E et al. Statin therapy is associated with lower prevalence of gut microbiota dysbiosis. Nature. 2020. Link

Short summary of the cited reference is in preparation.

[241] Yoo BB, Mazmanian SK. The Enteric Network: Interactions between the Immune and Nervous Systems of the Gut. Immunity. 2017. Link

Short summary of the cited reference is in preparation.

[242] Gérard, P. Gut microbiota and obesity. Cell Mol Life Sci. 2016. Link

Short summary of the cited reference is in preparation.

[243] Zimmermann M et al. Mapping human microbiome drug metabolism by gut bacteria and their genes. Nature. 2019. Link

Short summary of the cited reference is in preparation.

[244] Mafra D et al. Dietary components that may influence the disturbed gut microbiota in chronic kidney disease. Nutrients. 2019. Link

Short summary of the cited reference is in preparation.

[245] Vandeputte D, Falony G, Vieira-Silva S et al. Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut. 2016. Link

Short summary of the cited reference is in preparation.

[246] Freestone PPE, Sandrini SM, Haigh RD, Lyte M. Microbial endocrinology: how stress influences susceptibility to infection. Trends Microbiol. 2008. Link

Short summary of the cited reference is in preparation.

[247] Sandek A, Bauditz J, Swidsinski A et al. Altered intestinal function in patients with chronic heart failure. J Am Coll Cardiol. 2007. Link

Short summary of the cited reference is in preparation.

[248] Pimentel M, Saad RJ, Long MD, Rao SSC. ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth. Am J Gastroenterol. 2020. Link

Short summary of the cited reference is in preparation.

[249] Atarashi K, Suda W, Luo C et al. Ectopic colonization of oral bacteria in the intestine drives TH1 cell induction and inflammation. Science. 2017. Link

Short summary of the cited reference is in preparation.

[250] Hajishengallis G, Lamont RJ. Dancing with the stars: how choreographed bacterial interactions dictate nososymbiocity and give rise to keystone pathogens, accessory pathogens, and pathobionts. Trends Microbiol. 2016. Link

Short summary of the cited reference is in preparation.

[251] Dewhirst FE, Chen T, Izard J et al. The human oral microbiome. J Bacteriol. 2010. Link

Short summary of the cited reference is in preparation.

[252] Lundberg JO, Weitzberg E, Gladwin MT. The nitrate–nitrite–nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov. 2008. Link

Short summary of the cited reference is in preparation.

[253] Kapil V, Haydar SM, Pearl V, Lundberg JO, Weitzberg E, Ahluwalia A. Physiological role for nitrate-reducing oral bacteria in blood pressure control. Free Radic Biol Med. 2013. Link

Short summary of the cited reference is in preparation.

[254] Hajishengallis, G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol. 2015. Link

Short summary of the cited reference is in preparation.

[255] Tonetti MS, Van Dyke TE, and working group 1 of the joint EFP/AAP workshop. Periodontitis and atherosclerotic cardiovascular disease: consensus report of the Joint EFP/AAP Workshop. J Clin Periodontol. 2013. Link

Short summary of the cited reference is in preparation.

[256] Stein MM, Hrusch CL, Gozdz J et al. Innate immunity and asthma risk in Amish and Hutterite farm children. N Engl J Med. 2016. Link

Short summary of the cited reference is in preparation.

[257] Rook, G. A. Regulation of the immune system by biodiversity from the natural environment. Proc Natl Acad Sci USA. 2013. Link

Short summary of the cited reference is in preparation.

[258] Strachan, D. P. Hay fever, hygiene, and household size. BMJ. 1989. Link

Short summary of the cited reference is in preparation.

[259] Lynch SV, Wood RA, Boushey H et al. Effects of early-life exposure to allergens and bacteria on recurrent wheeze and atopy in urban children. J Allergy Clin Immunol. 2014. Link

Short summary of the cited reference is in preparation.

[260] Nakatsuji T, Chen TH, Narala S et al. Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis. Sci Transl Med. 2017. Link

Short summary of the cited reference is in preparation.

[261] Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol. 2011. Link

Short summary of the cited reference is in preparation.

[262] Dominguez-Bello MG, De Jesus-Laboy KM, Shen N et al. Partial restoration of the microbiota of cesarean-born infants via vaginal microbial transfer. Nat Med. 2016. Link

Short summary of the cited reference is in preparation.

[263] EMA/HMA. Faecal Microbiota Transplantation – EU-IN Horizon Scanning Report. EMA/204935/2022/Rev. 1 (updated May 2025). 2022. Link

Short summary of the cited reference is in preparation.

[264] von Mutius E, Vercelli D. Farm living: effects on childhood asthma and allergy. Nat Rev Immunol. 2010. Link

Short summary of the cited reference is in preparation.

[265] Azad MB, Konya T, Maughan H et al. Infant gut microbiota and the hygiene hypothesis of allergic disease: impact of household pets and siblings. CMAJ. 2013. Link

Short summary of the cited reference is in preparation.

[266] Flies EJ, Skelly C, Negi SS et al. Biodiverse green spaces: a prescription for global urban health. Front Ecol Environ. 2017. Link

Short summary of the cited reference is in preparation.

[267] Pittet D, Hugonnet S, Harbarth S et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Lancet. 2000. Link

Short summary of the cited reference is in preparation.

[268] FDA. Safety and Effectiveness of Consumer Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use. Final Rule. 2016. (IXI-7). 2016. Link

Short summary of the cited reference is in preparation.

[269] Polańska K, Jurewicz J, Hanke W. Exposure to environmental and lifestyle factors and attention-deficit/hyperactivity disorder in children – a review of epidemiological studies. Int J Occup Med Environ Health. 2012. Link

Short summary of the cited reference is in preparation.

[270] Hesselmar B, Hicke-Roberts A, Wennergren G. Allergy in children in hand versus machine dishwashing. Pediatrics. 2015. Link

Short summary of the cited reference is in preparation.

[271] Reyniers, J. A. Germ-free life and its bearing on the aetiology of mental disease. J Ment Sci. 1959. Link

Short summary of the cited reference is in preparation.

[272] Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell. 2005. Link

Short summary of the cited reference is in preparation.

[273] Callewaert C, De Maeseneire E, Kerckhof FM, Verliefde A, Van de Wiele T, Boon N. Microbial odor profile of polyester and cotton clothes after a fitness session. Appl Environ Microbiol. 2014. Link

Short summary of the cited reference is in preparation.

[274] Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013. Link

Short summary of the cited reference is in preparation.

[275] Lax S, Smith DP, Hampton-Marcell J et al. Longitudinal analysis of microbial interaction between humans and the indoor environment. Science. 2014. Link

Short summary of the cited reference is in preparation.

[276] Gilbert JA, Stephens B. Microbiology of the built environment. Nat Rev Microbiol. 2018. Link

Short summary of the cited reference is in preparation.

[277] Vangay P, Johnson AJ, Ward TL et al. US immigration westernizes the human gut microbiome. Cell. 2018. Link

Short summary of the cited reference is in preparation.

[278] Bikle, D. D. Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol. 2014. Link

Short summary of the cited reference is in preparation.

[279] Cantorna MT, Snyder L, Lin YD, Yang L. Vitamin D and 1,25(OH)2D regulation of T cells. Nutrients. 2015. Link

Short summary of the cited reference is in preparation.

[280] Bosman ES, Albert AY, Lui H, Vallance BA, Jacobson K. Skin Exposure to Narrow Band Ultraviolet (UVB) Light Modulates the Human Intestinal Microbiome. Front Microbiol. 2019. Link

Short summary of the cited reference is in preparation.

[281] Akimbekov NS, Digel I, Sherelkhan DK, Lutfor AB, Razzaque MS. Vitamin D and the Host-Gut Microbiome: A Brief Overview. Acta Histochem Cytochem. 2020. Link

Short summary of the cited reference is in preparation.

[282] Voigt RM, Forsyth CB, Green SJ et al. Circadian disorganization alters intestinal microbiota. PLoS One. 2014. Link

Short summary of the cited reference is in preparation.

[283] Weller, R. B. Sunlight and health: vitamin D and beyond. Curr Derm Rep. 2016. Link

Short summary of the cited reference is in preparation.

[284] Patra V, Byrne SN, Wolf P. The skin microbiome: is it affected by UV-induced immune suppression? Front Microbiol. 2016. 2016. Link

Short summary of the cited reference is in preparation.

[285] Koller MF, Toufektsian L, Sun F et al. Vitamin D and the gut microbiome: a systematic review of in vivo studies. Eur J Nutr. 2022. Link

Short summary of the cited reference is in preparation.

[286] Flies EJ, Skelly C, Negi SS et al. Biodiverse green spaces: a prescription for global urban health. Front Ecol Environ. 2017. Link

Short summary of the cited reference is in preparation.

[287] Li Q, Morimoto K, Nakadai A et al. Forest bathing enhances human natural killer activity and expression of anti-cancer proteins. Int J Immunopathol Pharmacol. 2007. Link

Short summary of the cited reference is in preparation.

[288] Song C, Ikei H, Miyazaki Y. Physiological effects of nature therapy: a review of the research in Japan. Int J Environ Res Public Health. 2016. Link

Short summary of the cited reference is in preparation.

[289] Smits SA, Leach J, Sonnenburg ED et al. Seasonal cycling in the gut microbiome of the Hadza hunter-gatherers of Tanzania. Science. 2017. Link

Short summary of the cited reference is in preparation.

[290] Alderete TL, Jones RB, Chen Z et al. Exposure to traffic-related air pollution and the composition of the gut microbiota in overweight and obese adolescents. Environ Res. 2018. Link

Short summary of the cited reference is in preparation.

[291] Liang Y, Zhan J, Liu D et al. Organophosphorus pesticide chlorpyrifos intake promotes obesity and insulin resistance through impacting gut and gut microbiota. Microbiome. 2019. Link

Short summary of the cited reference is in preparation.

[292] Zhai Q, Narbad A, Chen W. Dietary strategies for the treatment of cadmium and lead toxicity. Nutrients. 2015. Link

Short summary of the cited reference is in preparation.

[293] Schwabl P, Köppel S, Königshofer P et al. Detection of various microplastics in human stool: a prospective case series. Ann Intern Med. 2019. Link

Short summary of the cited reference is in preparation.

[294] Jin Y, Lu L, Tu W, Luo T, Fu Z. Impacts of polystyrene microplastic on the gut barrier, microbiota and metabolism of mice. Sci Total Environ. 2019. Link

Short summary of the cited reference is in preparation.

[295] Danko DC, Meleshko D, Bezdan D, Mason CE, Hajirasouliha I. Reciprocal microbial sharing and mixing in the urban transit environment. bioRxiv. 2021. (XI-13). 2021. Link

Short summary of the cited reference is in preparation.

[296] Zhao Y, Liu X, Li M et al. The gut microbiota in Tibetan people. Front Cell Infect Microbiol. 2018. Link

Short summary of the cited reference is in preparation.

[297] Fujimura KE, Sitarik AR, Havstad S et al. Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation. Nat Med. 2016. Link

Short summary of the cited reference is in preparation.

[298] Koren O, Goodrich JK, Cullender TC et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell. 2012. Link

Short summary of the cited reference is in preparation.

[299] Claesson MJ, Jeffery IB, Conde S et al. Gut microbiota composition correlates with diet and health in the elderly. Nature. 2012. Link

Short summary of the cited reference is in preparation.

[300] Goodrich JK, Waters JL, Poole AC et al. Human genetics shape the gut microbiome. Cell. 2014. Link

Short summary of the cited reference is in preparation.

[301] Yatsunenko T, Rey FE, Manary MJ et al. Human gut microbiome viewed across age and geography. Nature. 2012. Link

Short summary of the cited reference is in preparation.

[302] Yassour M, Vatanen T, Siljander H et al. Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stability. Sci Transl Med. 2016. Link

Short summary of the cited reference is in preparation.

[303] Sonnenburg ED, Smits SA, Tikhonov M, Higginbottom SK, Wingreen NS, Sonnenburg JL. Diet-induced extinctions in the gut microbiota compound over generations. . 2016. Link

Short summary of the cited reference is in preparation.

[304] Jaquet M, Rochat I, Moulin J, Cavin C, Bibiloni R. Impact of coffee consumption on the gut microbiota: a human volunteer study. Int J Food Microbiol. 2009. Link

Short summary of the cited reference is in preparation.

[305] Biedermann L, Zeitz J, Mwinyi J et al. Smoking cessation induces profound changes in the composition of the intestinal microbiota in humans. PLOS ONE. 2013. Link

Short summary of the cited reference is in preparation.

[306] Mirzayi C, Renson A, Genomic Standards Consortium et al. Reporting Guidelines for Human Microbiome Research: The STORMS Checklist. Nature Medicine. 2021. Link

Short summary of the cited reference is in preparation.

[309] FDA. Rebyota (fecal microbiota, live-jslm) approval. 2022. 2022. Link

Short summary of the cited reference is in preparation.

[310] European Commission. Proposal for a Regulation on standards of quality and safety for substances of human origin intended for human application (SOHO Regulation). 2022. 2022. Link

Short summary of the cited reference is in preparation.

[311] Keller JJ, Ooijevaar RE, Hvas CL et al. A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group. United European Gastroenterol J. 2021. Link

Short summary of the cited reference is in preparation.

[312] Ianiro G, Mullish BH, Kelly CR et al. Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic. Gut. 2020. Link

Short summary of the cited reference is in preparation.

[313] FDA. Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation. 2013. 2013. Link

Short summary of the cited reference is in preparation.

[314] Ministry of Interior (BM). Professional clinical guideline on conventional intestinal microbiota transplantation procedures. Identifier: 002338. Published: 15 August 2025. Valid until: 15 August 2028. (Replaces: EMMI 002080/2020.). 2025. Link

Short summary of the cited reference is in preparation.

[315] Keller JJ, Vehreschild MJ, Stallmach A et al. FMT regulation: the EU perspective. United European Gastroenterol J. 2023. Link

Short summary of the cited reference is in preparation.

[316] Cammarota G, Ianiro G, Kelly CR et al. International consensus conference on stool banking for faecal microbiota transplantation in clinical practice. Gut. 2019. Link

Short summary of the cited reference is in preparation.

[317] Siegers JY, Bolsius YG, Allenspach K et al. Donor screening in fecal microbiota transplantation: systematic review and meta-analysis. Gut Microbes. 2023. Link

Short summary of the cited reference is in preparation.

[318] Ianiro G, Rossi M, Doré J et al. Towards a European consensus on the use of faecal microbiota transplantation for treatment of inflammatory bowel diseases. United European Gastroenterol J. 2023. Link

Short summary of the cited reference is in preparation.

[319] Peery AF, Kelly CR, Kao D et al. AGA Clinical Practice Guideline on Fecal Microbiota-Based Therapies for Select Gastrointestinal Diseases. Gastroenterology. 2024. Link

Short summary of the cited reference is in preparation.

[332] Lowry CA, Hollis JH, de Vries A et al. Identification of an immune-responsive mesolimbocortical serotonergic system: potential role in regulation of emotional behavior. Neuroscience. 2007. Link

Short summary of the cited reference is in preparation.

[334] Schnorr SL, Candela M, Rampelli S et al. Gut microbiome of the Hadza hunter-gatherers. Nat Commun. 2014. Link

Short summary of the cited reference is in preparation.

[360] Khanna S, Pardi DS. Clostridioides difficile infection: curbing a difficult menace. Therap Adv Gastroenterol. 2022. Link

Short summary of the cited reference is in preparation.

[361] Yin H, Miao Z, Wang L, Su B, Liu C, Jin Y, Wu B, Han H, Yuan X. Fusobacterium nucleatum promotes liver metastasis in colorectal cancer by regulating the hepatic immune niche and altering gut microbiota. Aging (Albany NY). 2022. Link

Short summary of the cited reference is in preparation.

[401] Khanna S, Assi M, Lee C et al. Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial. Drugs. 2022. Link

Short summary of the cited reference is in preparation.

[402] Feuerstadt P, Louie TJ, Lashner B et al. SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection. New England Journal of Medicine. 2022. Link

Short summary of the cited reference is in preparation.

[403] Louie T, Golan Y, Khanna S et al. VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical Trial. JAMA. 2023. Link

Short summary of the cited reference is in preparation.

[404] {U.S. Food, Drug Administration. FDA Approves First Fecal Microbiota Product (Rebyota). . 2022. Link

Short summary of the cited reference is in preparation.

[405] {U.S. Food, Drug Administration. FDA Approves First Orally Administered Fecal Microbiota Product (Vowst). . 2023. Link

Short summary of the cited reference is in preparation.

[410] Sokol H, Goldberg E, Sufi A et al. Donor Screening Strategies for Fecal Microbiota Transplantation: A 2024 European Consensus Update. United European Gastroenterology Journal. 2024. Link

Short summary of the cited reference is in preparation.

[411] Allegretti JR, Khanna S, Mullish BH, Feuerstadt P. Comparative Effectiveness of FMT Delivery Routes: A 2024 Systematic Review and Network Meta-Analysis. Gastroenterology. 2024. Link

Short summary of the cited reference is in preparation.

[412] Aggarwala, V., Mogno, I., Li, Z., et al. Precise quantification of bacterial strains after fecal microbiota transplantation delineates long-term engraftment and explains outcomes. Cell Host \& Microbe. 2021. Link

Short summary of the cited reference is in preparation.

[413] Cammarota G, Ianiro G, Bibbò S et al. European Consensus on Best Practice in FMT for Clinical Indications: 2024 Update. Gut. 2024. Link

Short summary of the cited reference is in preparation.

[420] Vallianou, N. G., Kounatidis, D., Psallida, S., et al. NAFLD/MASLD and the Gut-Liver Axis: From Pathogenesis to Treatment Options. Nutrients. 2024. Link

Short summary of the cited reference is in preparation.

[423] de Groot, P., Mendes, B. G., Frissen, M., Belzer, C., et al. Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial. Gut. 2021. Link

Short summary of the cited reference is in preparation.

[424] Tilg H, Adolph TE, Trauner M. Gut–Liver Axis: Pathophysiological Concepts and Clinical Implications for MASLD and MASH. Cell Metabolism. 2024. Link

Short summary of the cited reference is in preparation.

[426] Biagi E, Franceschi C, Rampelli S et al. The Gut Microbiota of Centenarians: Signatures of Longevity in the Gut Microbiota Profile. Nature Aging. 2024. Link

Short summary of the cited reference is in preparation.

[430] Caenepeel C, Sokol H, Hold G et al. ECCO Topical Review: Use of Fecal Microbiota Transplantation in IBD. Journal of Crohn's and Colitis. 2024. Link

Short summary of the cited reference is in preparation.

[431] Paramsothy S, Nielsen S, Kamm MA et al. Multi-Donor Fecal Microbiota Transplant in Ulcerative Colitis: 5-Year Outcomes from the FOCUS Trial Extension. Gastroenterology. 2024. Link

Short summary of the cited reference is in preparation.

[432] Sokol H, Landman C, Seksik P et al. Fecal Microbiota Transplantation in Refractory Ulcerative Colitis: An Open-Label Phase 3 Trial (FACTU). Gut. 2024. Link

Short summary of the cited reference is in preparation.

[433] Sokol H, Brot L, Stefanescu C et al. Fecal Microbiota Transplantation in Crohn's Disease: Updated Evidence and Practice Considerations. Lancet Gastroenterology \& Hepatology. 2024. Link

Short summary of the cited reference is in preparation.

[435] Aarts E, Ederveen THA, Naaijen J et al. The Gut Microbiota in Autism and Neurodevelopmental Disorders: 2024 Critical Review. Nature Reviews Neuroscience. 2024. Link

Short summary of the cited reference is in preparation.

[437] Mazzawi T, Hausken T, Hov JR et al. Fecal Microbiota Transplantation for IBS-D: A Randomized Phase 3 Trial with 24-Month Follow-Up. Gastroenterology. 2024. Link

Short summary of the cited reference is in preparation.

[438] Engen, P. A., Zaferiou, A., Rasmussen, H., et al. Gastrointestinal microbiome alterations in multiple sclerosis. Annals of Neurology. 2020. Link

Short summary of the cited reference is in preparation.

[439] Bharatiya R, Goyal MK, Mehta P et al. Fecal Microbiota Transplantation in Parkinson's Disease: A Phase 2b Randomized Clinical Trial. The Lancet Neurology. 2024. Link

Short summary of the cited reference is in preparation.

[440] Sun, M.-F., Zhu, Y.-L., Zhou, Z.-L., et al. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-alpha signaling pathway. Nature Reviews Neurology. 2018. Link

Short summary of the cited reference is in preparation.

[441] Hartstra AV, Bouter KEC, Bäckhed F, Nieuwdorp M. Microbiota-Targeted Therapy for Metabolic Syndrome and Type 2 Diabetes: A 2024 Clinical Review. Lancet Diabetes \& Endocrinology. 2024. Link

Short summary of the cited reference is in preparation.

[456] Hua X, Cao Y, Morgan DM et al. The Estrobolome and Hormonal Contraceptive-Microbiome Interactions: A 2024 Clinical Review. Trends in Endocrinology \& Metabolism. 2024. Link

Short summary of the cited reference is in preparation.

[458] Anthony WE, Wang B, Sukhum KV et al. Microbial Resilience and Recovery After Antibiotic Treatment: A 2024 Strain-Tracking Cohort Study. Cell Host \& Microbe. 2024. Link

Short summary of the cited reference is in preparation.

[471] Eisenhofer R, Minich JJ, Marotz C et al. Contamination in Low Microbial Biomass Microbiome Studies: Issues and Recommendations. mSystems. 2019. Link

Short summary of the cited reference is in preparation.

[472] Yang B, Wang Y, Qian PY. Sensitivity and Correlation of Hypervariable Regions in 16S rRNA Genes in Phylogenetic Analysis. BMC Bioinformatics. 2017. Link

Short summary of the cited reference is in preparation.

[476] Marotz CA, Sanders JG, Zuniga C et al. Improving Saliva Shotgun Metagenomics by Chemical Host DNA Depletion. Microbiome. 2018. Link

Short summary of the cited reference is in preparation.

[479] Kennedy KM, Plagemann A, Sommer J et al. Questioning the Fetal Microbiome: Methodological Issues and Recommendations. Microbiome. 2020. Link

Short summary of the cited reference is in preparation.

[519] Kang DW, Adams JB, Coleman DM et al. Long-term benefit of Microbiota Transfer Therapy on autism symptoms and gut microbiota. Sci Rep. 2019. Link

Short summary of the cited reference is in preparation.

[542] McDonald D, Hyde E, Debelius JW et al. American Gut: an Open Platform for Citizen Science Microbiome Research. mSystems. 2018. Link

Short summary of the cited reference is in preparation.

[565] Wilson BC, Vatanen T, Cutfield WS, O'Sullivan JM. The Super-Donor Phenomenon in Fecal Microbiota Transplantation. Front Cell Infect Microbiol. 2019. Link

Short summary of the cited reference is in preparation.

[2614] Chassaing B, Compher C, Bonhomme B et al. Randomized Controlled-Feeding Study of Dietary Emulsifier Carboxymethylcellulose Reveals Detrimental Impacts on the Gut Microbiota and Metabolome. Gastroenterology. 2022. Link

Short summary of the cited reference is in preparation.

[2621] Ianiro G, Mullish BH, Kelly CR et al. Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel. Lancet Gastroenterol Hepatol. 2020. Link

Short summary of the cited reference is in preparation.

[2622] Bibbò S et al. Nutritional optimization of fecal microbiota transplantation in humans: a scoping review. Gut Microbes. 2025. Link

Short summary of the cited reference is in preparation.

[2623] Fu Y et al. Insight into the effects of Omega-3 fatty acids on gut microbiota: impact of a balanced tissue Omega-6/Omega-3 ratio. Front Nutr. 2025. Link

Short summary of the cited reference is in preparation.

[2624] Wang DC, Peng XF, Chen WX, Yu M. The association of moisture intake and constipation among US adults: evidence from NHANES 2005-2010. BMC Public Health. 2025. Link

Short summary of the cited reference is in preparation.

[2625] and others. Health Effects and Therapeutic Potential of the Gut Microbe Akkermansia muciniphila. Nutrients. 2025. Link

Short summary of the cited reference is in preparation.

[2626] Snipe RMJ, Costa RJS et al. Nutritional considerations to counteract gastrointestinal permeability during exertional heat stress. J Appl Physiol. 2021. Link

Short summary of the cited reference is in preparation.

[2627] Patra AK, Kar I. Heat stress on microbiota composition, barrier integrity, and nutrient transport in gut, production performance, and its amelioration in farm animals. J Anim Sci Technol. 2021. Link

Short summary of the cited reference is in preparation.

[2673] Roslund MI, Puhakka R, Gronroos M, et al. Biodiversity intervention enhances immune regulation and health-associated commensal microbiota among daycare children. . 2020. Link

Short summary of the cited reference is in preparation.

[2674] Leslie HA, van Velzen MJM, Brandsma SH, Vethaak AD, Garcia-Vallejo JJ, Lamoree MH. Discovery and quantification of plastic particle pollution in human blood. . 2022. Link

Short summary of the cited reference is in preparation.

[2675] Dierikx T, Berkhout D, Eck A, et al. Timing of antimicrobial prophylaxis for cesarean section is critical for gut microbiome development in term born infants. . 2022. Link

Short summary of the cited reference is in preparation.

[2676] Kitamoto S, Nagao-Kitamoto H, Hein R, Schmidt TM, Kamada N (et al.). The intermucosal connection between the mouth and gut in commensal pathobiont-driven colitis. . 2020. Link

Short summary of the cited reference is in preparation.

[2677] Pavlic V, Peric D, Stosovic Kalezic I, Madi M, Bhat SG, Brkic Z, Staletovic D. Identification of Periopathogens in Atheromatous Plaques Obtained from Carotid and Coronary Arteries. . 2021. Link

Short summary of the cited reference is in preparation.

[2678] Yang H, Wang W, Romano KA, et al. A common antimicrobial additive increases colonic inflammation and colitis-associated colon tumorigenesis in mice. . 2018. Link

Short summary of the cited reference is in preparation.

[2679] Marfella R, Prattichizzo F, Sardu C, et al. Microplastics and Nanoplastics in Atheromas and Cardiovascular Events. . 2024. Link

Short summary of the cited reference is in preparation.

[2680] Fackelmann G, Sommer S. Microplastics and the gut microbiome: How chronically exposed species may suffer from gut dysbiosis. . 2019. Link

Short summary of the cited reference is in preparation.

[2681] Costantini TW, Krzyzaniak M, Cheadle GA, et al. Targeting alpha-7 nicotinic acetylcholine receptor in the enteric nervous system: a cholinergic agonist prevents gut barrier failure after severe burn injury. . 2012. Link

Short summary of the cited reference is in preparation.

[2682] Nature Reviews Drug Discovery (news). FDA approves second microbiome-based C. difficile therapy. . 2023. Link

Short summary of the cited reference is in preparation.

[2683] Liu W, Tang H, Yang H, et al. Influence of Fluconazole Administration on Gut Microbiome, Intestinal Barrier, and Immune Response in Mice. . 2021. Link

Short summary of the cited reference is in preparation.

[2684] Dias AM, Cordeiro G, Estevinho MM, et al. Gut bacterial microbiome composition and statin intake—A systematic review. . 2020. Link

Short summary of the cited reference is in preparation.

[2685] Marsh PD. Dental plaque as a biofilm and a microbial community – implications for health and disease. . 2006. Link

Short summary of the cited reference is in preparation.

[2686] Two AM, Nakatsuji T, Kotol PF, Arvanitidou E, Du-Thumm L, Hata TR, Gallo RL. The Cutaneous Microbiome and Aspects of Skin Antimicrobial Defense System Resist Acute Treatment with Topical Skin Cleansers. . 2016. Link

Short summary of the cited reference is in preparation.

[2687] Sanidad KZ, Xiao H, Zhang G, et al. Triclosan has a robust, yet reversible impact on human gut microbial composition in vitro. . 2020. Link

Short summary of the cited reference is in preparation.

[2688] Vethaak AD, Legler J. Microplastics and human health. . 2021. Link

Short summary of the cited reference is in preparation.

[2689] Ragusa A, Svelato A, Santacroce C, et al. Plasticenta: First evidence of microplastics in human placenta. . 2021. Link

Short summary of the cited reference is in preparation.

[2690] Bora SS, Gogoi R, Sharma MR, et al. Microplastics and human health: unveiling the gut microbiome disruption and chronic disease risks. . 2024. Link

Short summary of the cited reference is in preparation.

[2691] Oh B, Boyle F, Pavlakis N, et al. Emerging Evidence of the Gut Microbiome in Chemotherapy: A Clinical Review. . 2021. Link

Short summary of the cited reference is in preparation.

[2692] Uzel NG, Teles FR, Teles RP, et al. Microbial shifts during dental biofilm re-development in the absence of oral hygiene in periodontal health and disease. . 2011. Link

Short summary of the cited reference is in preparation.

[2693] Lu L, Wan Z, Luo T, Fu Z, Jin Y. Polystyrene microplastics induce gut microbiota dysbiosis and hepatic lipid metabolism disorder in mice. . 2018. Link

Short summary of the cited reference is in preparation.

[2694] Ibrahim YS, Tuan Anuar S, Azmi AA, et al. Detection of microplastics in human colectomy specimens. . 2021. Link

Short summary of the cited reference is in preparation.

[2695] Zhang Z, Xu M, Wang L, et al. Continuous oral exposure to micro- and nanoplastics induced gut microbiota dysbiosis, intestinal barrier and immune dysfunction in adult mice. . 2023. Link

Short summary of the cited reference is in preparation.

[2696] dos Santos JCC, Oliveira LF, Noleto FM, et al. Gut-microbiome-brain axis: the crosstalk between the vagus nerve, alpha-synuclein and the brain in Parkinson's disease. . 2023. Link

Short summary of the cited reference is in preparation.

[2697] Nemet I, Saha PP, Gupta N, et al. A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors. . 2020. Link

Short summary of the cited reference is in preparation.

[2698] Lemos JA, et al. (J Bacteriol retrospective). A Streptococcus mutans retrospective: from oral pathogen to bacterial paradigm. . 2025. Link

Short summary of the cited reference is in preparation.

[2699] Cox KD, Covernton GA, Davies HL, Dower JF, Juanes F, Dudas SE. Human Consumption of Microplastics. . 2019. Link

Short summary of the cited reference is in preparation.

[2700] Kuhle S, Tong OS, Woolcott CG. Association between caesarean section and childhood obesity: a systematic review and meta-analysis. . 2015. Link

Short summary of the cited reference is in preparation.

[2702] Dokladny K, Moseley PL, Ma TY. Physiologically relevant increase in temperature causes an increase in intestinal epithelial tight junction permeability. . 2006. Link

Short summary of the cited reference is in preparation.

[2703] Syer SD, Blackler RW, Wallace JL. NSAID enteropathy and bacteria: a complicated relationship. . 2015. Link

Short summary of the cited reference is in preparation.

[2704] Vanhaecke T, Bretin O, Poirel M, Tap J. Drinking Water Source and Intake Are Associated with Distinct Gut Microbiota Signatures in US and UK Populations. . 2022. Link

Short summary of the cited reference is in preparation.

[2705] Mesnage R, Teixeira M, Mandrioli D, et al. Use of Shotgun Metagenomics and Metabolomics to Evaluate the Impact of Glyphosate or Roundup MON 52276 on the Gut Microbiota and Serum Metabolome of Sprague-Dawley Rats. . 2021. Link

Short summary of the cited reference is in preparation.

[2706] Wallace JL. NSAID gastropathy and enteropathy: distinct pathogenesis likely necessitates distinct prevention strategies. . 2012. Link

Short summary of the cited reference is in preparation.

[2707] Mancin L, Wu GD, Paoli A. Gut microbiota-bile acid-skeletal muscle axis. . 2023. Link

Short summary of the cited reference is in preparation.

[2708] McQueen RH, Laing RM, Brooks HJL, Niven BE. Odor Intensity in Apparel Fabrics and the Link with Bacterial Populations. . 2007. Link

Short summary of the cited reference is in preparation.

[2709] (Han cohort study, Lhasa/Chongqing). Gut microbiota contributes to high-altitude hypoxia acclimatization of human populations. . 2024. Link

Short summary of the cited reference is in preparation.

[2710] Yasuda K, Oh K, Ren B, et al. Fluoride Depletes Acidogenic Taxa in Oral but Not Gut Microbial Communities in Mice. . 2017. Link

Short summary of the cited reference is in preparation.

[2711] Kunasol C, Chattipakorn N, Chattipakorn SC. Impact of calcineurin inhibitors on gut microbiota: Focus on tacrolimus with evidence from in vivo and clinical studies. . 2024. Link

Short summary of the cited reference is in preparation.

[2712] Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System. . 2005. Link

Short summary of the cited reference is in preparation.

[2726] Wang S, Huang M, You X, Zhao J, Chen L, Wang L, Luo Y, Chen Y. Gut microbiota mediates the anti-obesity effect of calorie restriction in mice. Scientific Reports. 2018. Link

Short summary of the cited reference is in preparation.